A case of advanced hepatocellular carcinoma with hepatitis C virus infection treated effectively with Peg-IFNα2a-Reference-Cited by-同舟云学术

A case of advanced hepatocellular carcinoma with hepatitis C virus infection treated effectively with Peg-IFNα2a

Published:2015 Issue:6 Volume:56 Page:280-288
ISSN:0451-4203
Container-title:Kanzo
language:en
Short-container-title:Acta hepatologica Japonica

Author:

Iwamoto Takayuki¹,Fukuda Kazuto¹,Sawai Yoshiyuki¹,Kogita Sachiyo¹,Igura Takumi¹,Onishi Atsunori¹,Yagi Mai¹,Tani Mizuki¹,Yasuoka Hidetaka¹,Okabe Junya¹,Yamagata Yosuke¹,Matsumoto Yasushi¹,Nakahara Masanori¹,Zushi Shinichiro¹,Marukawa Taro²,Ohashi Hiroshi³,Takiuchi Daisuke⁴,Morimoto Osakuni⁴,Shibata Kunitaka⁴,Imai Yasuharu¹

Affiliation:

1. Department of Gastroenterology, Ikeda Municipal Hospital

2. Department of Radiology, Ikeda Municipal Hospital

3. Department of Diagnostic Pathology, Ikeda Municipal Hospital

4. Department of Gastroenterological Surgery, Ikeda Municipal Hospital

Publisher

Japan Society of Hepatology

Subject

Hepatology

Link

https://www.jstage.jst.go.jp/article/kanzo/56/6/56_280/_pdf

Reference24 articles.

1. 2) Lai CL, Lau JY, Wu PC, et al. Recombinant interferon-alpha in inoperable hepatocellular carcinoma: a randomized controlled trial. Hepatology 1993; 17: 389-394

2. Two cases of advanced hepatocellular carcinoma successfully treated with Peg-INFα2a once every 2 weeks as a single agent

3. 4) Obi S, Yoshida H, Toune R, et al. Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer 2006; 106: 1990-1997

4. 5) Sakon M, Nagano H, Dono K, et al. Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer 2002; 94: 435-442

5. 6) Chung YH, Song BC, Lee GC, et al. Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Cancer 2000; 88: 1986-1991